XCOPRI 50 MG COM REV + 100 MG COM REV CT BL AL PLAS COM REV CT BL AL PLAS PVC/PE/PVDC TRANS X 14 + 14
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1004315780205 -
GGREM
508026070208607 -
Código de barras
7891317054892
O que a fonte publica
- Detentor do registro
- EUROFARMA LABORATORIOS S.A.
- Princípios ativos
- CENOBAMATO
- Embalagem
- 50 MG COM REV + 100 MG COM REV CT BL AL PLAS COM REV CT BL AL PLAS PVC/PE/PVDC TRANS X 14 + 14
- Regime de dispensação
- Tarja Vermelha sob restrição
- Tipo de produto
- Novo
- Classe terapêutica
- N3A - ANTIEPILÉPTICOS
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
- XCOPRI 50 MG COM REV + 100 MG COM REV CT BL AL PLAS COM REV CT BL AL PLAS PVC/PE/PVDC TRANS X 14 + 14
- XCOPRI
- CENOBAMATO
Dados completos da fonte
{
"name": "XCOPRI 50 MG COM REV + 100 MG COM REV CT BL AL PLAS COM REV CT BL AL PLAS PVC/PE/PVDC TRANS X 14 + 14",
"holder": "EUROFARMA LABORATORIOS S.A.",
"stripe": "Tarja Vermelha sob restrição",
"barcodes": [
"7891317054892"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "508026070208607",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "61.190.096/0001-92",
"priceRegime": "Regulado",
"productName": "XCOPRI",
"productType": "Novo",
"hospitalOnly": false,
"presentation": "50 MG COM REV + 100 MG COM REV CT BL AL PLAS COM REV CT BL AL PLAS PVC/PE/PVDC TRANS X 14 + 14",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha sob restrição",
"factoryPrices": {
"icms-0": "305.36",
"icms-12": "347.00",
"icms-17": "367.90",
"icms-18": "372.39",
"icms-19": "376.99",
"icms-20": "381.70",
"icms-21": "386.53",
"icms-22": "391.49",
"icms-23": "396.57",
"icms-17.5": "370.13",
"icms-19.5": "379.33",
"icms-20.5": "384.10",
"icms-22.5": "394.01",
"icms-12-alc": "309.82",
"icms-17-alc": "328.49",
"icms-18-alc": "332.49",
"icms-19-alc": "336.60",
"icms-20-alc": "340.80",
"icms-21-alc": "345.12",
"icms-22-alc": "349.54",
"icms-23-alc": "354.08",
"withoutTaxes": "272.64",
"icms-17.5-alc": "330.48",
"icms-19.5-alc": "338.69",
"icms-20.5-alc": "342.95",
"icms-22.5-alc": "351.80"
},
"pisCofinsList": "Negativa",
"substanceText": "CENOBAMATO",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "409.63",
"icms-12": "465.49",
"icms-17": "493.52",
"icms-18": "499.55",
"icms-19": "505.72",
"icms-20": "512.04",
"icms-21": "518.52",
"icms-22": "525.17",
"icms-23": "531.98",
"icms-17.5": "496.52",
"icms-19.5": "508.86",
"icms-20.5": "515.26",
"icms-22.5": "528.55",
"icms-12-alc": "428.31",
"icms-17-alc": "454.12",
"icms-18-alc": "459.65",
"icms-19-alc": "465.33",
"icms-20-alc": "471.14",
"icms-21-alc": "477.11",
"icms-22-alc": "483.22",
"icms-23-alc": "489.49",
"withoutTaxes": "376.91",
"icms-17.5-alc": "456.87",
"icms-19.5-alc": "468.22",
"icms-20.5-alc": "474.11",
"icms-22.5-alc": "486.34"
},
"invalidBarcodes": [],
"activeSubstances": [
"CENOBAMATO"
],
"therapeuticClass": "N3A - ANTIEPILÉPTICOS",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1004315780205",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "N3A",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:508026070208607"